Chronicity of Anterior Cruciate Ligament Injury Does Not Adversely Affect the Clinical Outcomes of Primary Repair in Appropriately Selected Patients.

Mueller, Maximilian M; Conner-Rilk, Sebastian; Kunze, Kyle N; von Rehlingen-Prinz, Fidelius; Goodhart, Gabriel C; Tomanek, Fabian M; O'Brien, Robert J; van der List, Jelle P et al. · Arthroscopy · 2026

prospective_cohort · Level II

Where this comes from

Abstract

To determine the association between surgical delay, anterior cruciate ligament (ACL) tissue quality, failure rates, and clinical outcomes at a minimum 2-year follow-up after arthroscopic ACL primary repair (ACLPR). Consecutive patients with complete, proximal (type I/II) ACL tears who underwent arthroscopic ACLPR and had a minimum 2-year follow-up were included. Surgical delay was stratified into 3 categories: acute (≤21 days), subacute (22-90 days), and chronic (>90 days). Intraoperative tissue quality was assessed according to synovial sheath integrity (grade 1, completely intact; grade 2, >50% intact; grade 3, <50% intact) and rupture pattern (1-bundle, 2-bundle, and complex tear). Failure was defined as instrumented laxity >3 mm anterior tibial translation side-to-side difference, pivot shift grade ≥2, and/or subjective instability. Clinical and patient-reported outcomes were compared and Patient Acceptable Symptom State thresholds established. Between 2008 and 2021, 276 of 298 (loss to follow-up, 7.4%) patients (mean age, 39.7 ± 10.7 years; females, 50.3%) who underwent ACLPR with a follow-up of 2.9 ± 1.0 years (2.0-6.5 years) met the inclusion criteria. Sixty-eight (24.6%) ACLPR were acute, 152 (50.1%) subacute, and 56 (20.3%) chronic. Surgical delay was not significantly correlated with worse tissue quality (grade 2, P = .79; grade 3, P = .06) or increased failure risk (P = .57). ACLPR failure occurred in 28 patients (10.1%), with no significant differences among groups (acute, 10.2%; subacute, 11.2%; chronic, 7.1%; P = .76). Reoperation rates (P = .62) and anterior tibial translation side-to-side difference (P = .90), as well as patient-reported outcomes (all P > .28) and Patient Acceptable Symptom State threshold achievements (overall: International Knee Documentation Committee, 84.7%; Lysholm, 83.3%; Forgotten Joint Score-12, 87.3%; and ACL-Return to Sport after Injury, 88.5%) were comparable across groups (all P > .05). Injury chronicity did not adversely affect failure rates or clinical outcomes at minimum 2-year follow-up after ACLPR. Therefore, in the case of a proximal tear location and sufficient tissue quality, surgical delay alone should not be considered a contraindication for ACLPR. Level III, retrospective comparative case series.

Medical subject headings